Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation

Aim of the study: a systematic analysis of the modern literature data on the nivolumab monotherapy efficacy in patients with metastatic colorectal cancer (mCRC). Material and methods. The review summarizes the results of clinical studies of the nivolumab efficacy in patients with mCRC between 2012 a...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. N. Babyshkina, T. A. Dronova, P. A. Gervas, N. O. Popova, A. Yu. Dobrodeev, D. N. Kostromitsky, S. G. Afanasyev, V. E. Goldberg, N. V. Cherdyntseva
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2022-11-01
Series:	Сибирский онкологический журнал
Subjects:	metastatic colorectal cancer nivolumab recist atypical response patterns
Online Access:	https://www.siboncoj.ru/jour/article/view/2316
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma
by: Omer Faruk Kuzu, et al.
Published: (2025-07-01)

Variability in surgical treatment of metastatic colorectal cancer (literature review)
by: A. Yu. Dobrodeev, et al.
Published: (2023-05-01)

Nivolumab in real-life clinical practice
by: M. A. Lyadova, et al.
Published: (2019-12-01)

Multimodal therapy for metastatic colorectal cancer: a case of complete clinical and radiological response of liver metastases
by: A. Yu. Dobrodeev, et al.
Published: (2024-03-01)

The efficacy of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer: a retrospective study
by: An Tianqi, et al.
Published: (2022-08-01)

Herpes zoster granulomatous dermatitis in metastatic lung cancer treated with nivolumab: A case report
by: Elisa Gozzi, et al.
Published: (2020-05-01)

Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
by: Yu. M. Bychkov, et al.
Published: (2019-07-01)

Bullous pemphigoid associated with the use of nivolumab in a patient with metastatic melanoma: a case report.
by: Diego Lopes Paim Miranda, et al.
Published: (2020-01-01)

MODERN TREATMENT OF METASTATIC MELANOMA: FROM STANDARDS TO AN INDIVIDUALIZED APPROACH IN REAL CLINICAL PRACTICE
by: N. V. Zhukova, et al.
Published: (2018-06-01)

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience
by: K. V. Lepik, et al.
Published: (2019-01-01)

Modern strategy of metastatic colorectal cancer treatment (literature review)
by: O. I. Kit, et al.
Published: (2024-09-01)

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Vogt‐Koyanagi‐Harada disease‐like uveitis induced by nivolumab in metastatic renal cell carcinoma
by: Hitomi Imai, et al.
Published: (2025-01-01)

Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
by: A. Yu. Dobrodeev, et al.
Published: (2023-01-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
by: Valerie Glutsch, et al.
Published: (2024-12-01)

THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
by: M. I. Sluzhev, et al.
Published: (2021-10-01)

Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021-05-01)

Inter-reader agreement of RECIST and mRECIST criteria for assessing response to transarterial chemoembolization in hepatocellular carcinoma
by: Saeed Mohammadzadeh, et al.
Published: (2025-05-01)

Nivolumab-induced interstitial lung disease in the patient with melanoma
by: Marcin Morawski, et al.
Published: (2024-02-01)

Brazilian cohort results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
by: Celso Abdon Lopes de Mello, et al.
Published: (2022-12-01)

Applications and perspectives of metastatic colorectal cancer organoids
by: CUI Jingwei, et al.
Published: (2024-06-01)

Combined Use of Cabozantinib and Nivolumab in Clinical Practice
by: V. E. Askarov, et al.
Published: (2024-04-01)

How opportune is multigene testing in metastatic colorectal cancer? A review
by: Cristina Orlov-Slavu, et al.
Published: (2021-10-01)

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
by: Maria T. Bourlon, et al.
Published: (2025-07-01)

Treatment sequencing in metastatic colorectal cancer
by: Nanteznta Torounidou, et al.
Published: (2025-01-01)

Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01)

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
by: Birol Ocak, et al.
Published: (2024-09-01)

A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01)

The Desmoid Dilemma: Challenges and Opportunities in Assessing Tumor Burden and Therapeutic Response
by: Yu-Cherng Chang, et al.
Published: (2025-05-01)

Nivolumab in two cases of refractory mycosis fungoides erythroderma
by: Ewa Chmielowska
Published: (2021-12-01)

Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan
by: Tomoki Taniguchi, et al.
Published: (2024-12-01)

Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma
by: N. A. Avxentyev, et al.
Published: (2020-12-01)

Molecular symphonies and signalling pathways orchestrated by the gut microbiome in metastatic colorectal cancer (mCRC); a state-of-the-art review
by: Nayeralsadat Fatemi, et al.
Published: (2024-01-01)

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
by: Kozue Matsuishi, et al.
Published: (2020-06-01)

Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method
by: Anant Ramaswamy, et al.

Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
by: Heves Surmeli, et al.
Published: (2025-06-01)

Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis
by: N. Marschner, et al.
Published: (2024-06-01)

PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma
by: EA Demina
Published: (2018-07-01)